Joining Entasis Therapeutics are investors including Frazier Healthcare Partners, Novo A/S, and Eventide Funds, whose contribution builds on the $40 million start-up funding from AstraZeneca last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback